Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leichter, S. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leichter, S. B.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 22:5-7, 2004
© American Diabetes Association ®, Inc., 2004


The Business of Diabetes

Capital Equipment Investments in Diabetes Care

Steven B. Leichter, MD, FACP, FACE

The first 300 words of the full text of this article appear below.


    Introduction
 
Many health professionals involved in diabetes care have little or no experience in the acquisition of capital equipment. Until recently, there were few pieces of capital equipment that could be used in diabetes care, except for those in commercial laboratories. Diabetes health professionals who do not manage a commercial laboratory now have the opportunity to consider the use of a number of pieces of equipment that are designed for the medical office and not the laboratory environment. In this discussion, we consider the evaluation, purchase, and application of capital equipment for the office environment, or, capital equipment management for the neophyte.

There are a variety of devices available for use in diabetes. This article considers equipment that meets the following criteria:

  1. It is used by a health professional in a medical office or is applied and removed in a medical office;
  2. There is an intention to bill and the expectation to collect ethical charges from third-party payers for the use of the equipment;
  3. The equipment is sold on the premise that the reimbursements for its use will financially benefit the provider; and
  4. There is usually the expectation that the equipment will enhance the perceived excellence of the diabetes care rendered by the practitioner.


    Capital Equipment for Use in Diabetes Care
 
Although the number of items for use in diabetes care that fulfill the above criteria is not large, the list is certainly growing (Table 1). The items include desktop devices to measure hemoglobin A1c (A1C), glucose monitoring sensors, devices to assess neurological defects in diabetic patients, ultrasound devices to measure carotid wall atherosclerosis, and various cameras for assessment of retinopathic changes in diabetic people.


View this table:
[in this window]
[in a new window]
 
Table 1. Capital Equipment for Use in the Diabetes Care Office Environment

 
These devices vary in size, cost, and potential reimbursement; however, they all meet the criteria enumerated above. They are used or . . . [Full Text of this Article]


    Fiscal Assessment of Prospective Capital Equipment
 

    Examples of Capital Equipment Assessment
 

    Summary
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.